Prognostic analysis of 23 cases of undifferentiated thyroid carcinoma

Xin Yang

doi:10.62051/tbckjd30

Authors

Xin Yang

DOI:

https://doi.org/10.62051/tbckjd30

Keywords:

anaplastic thyroid carcinoma; treat; prognosis.

Abstract

Objective: To investigate the relationship between clinical features, treatment and prognosis of undifferentiated thyroid carcinoma. Methods: The clinical and follow-up data of 23 patients with undifferentiated thyroid carcinoma admitted to Chongqing University Cancer Hospital from March 2012 to September 2019 were retrospectively analyzed. Results: The median survival time of 23 patients with undifferentiated thyroid carcinoma was 15 weeks, 3-month survival time was 56.5%, 6-month survival rate was 39.1%, and 1-year survival rate was 30.4%. Univariate analysis showed that the size of primary tumor lesion, normal albumin, normal platelets, activated partial thrombin time, fibrinogen, thyroglobulin antibody and radiotherapy were the factors influencing the prognosis of undifferentiated thyroid cancer. The analysis of the effect of treatment on the prognosis showed that surgery, radiotherapy and combined treatment can obviously improve the prognosis. Multivariate analysis showed that the independent factors affecting prognosis were the diameter of the primary lesion, whether radiotherapy was given or not, the dose of radiotherapy, and whether radiotherapy was combined with surgery. Conclusion: The malignant degree of undifferentiated thyroid cancer is very high, so R0 or R1 resection of neck lesions plus radiotherapy should be taken as far as possible for patients with surgical opportunity, and the same effect may be achieved for patients who have lost the surgical opportunity. Anticoagulant and antiplatelet therapy may benefit patients.

Downloads

Download data is not yet available.

References

Iwao Sugitani, Akira Miyauchi, Kiminori Sugino, et a1. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. [J]. World J Surg.2012 Jun;36(6):1247-54.

Swaak-Krarglen AT, de Wilt JH, Sehmitz PI, et a1. Muhimadallty treatment for anaplastic thyroid carcinoma-Treatment outcome in 75 patients. Radiother Oncol, 2009, 92: 100-104.

Chandrakanth Are, Ashok R Shaha. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches [J]. Ann Surg Onco.2006 Apr; 13(4):453-64.

Wang LY, Nixon IJ, Patel SG, et al. Operative management of locally advanced, differentiated thyroid cancer. Surgery, 2016, 160(3): 738-46.

Sebastian Szubert, Rafal Moszynski, Dariusz Szpurek, et al.The expression of Platelet-derived Growth factor receptors (PDGFRs) and their correlation with overall survival of patients with ovarian cancer[J]. Ginekol Pol.2019; 90(5): 242-249.

Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J]. Cancer cell, 2011, 20(5): 576-590.

Schumacher D, Strilic B, Sivaraj KK, et al. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor[J]. Cancer cell, 2013, 24(1): 130-137.

Hammad Bhatti, Avinash Ramdass, James D Cury, et al. Operator dependent factors implicated in failure of non-invasive positive pressure ventilation (NIPPV) for respiratory failure[J]. Clin Respir J. 2017 Nov; 11(6): 901-905.

Zhongxing Liang, Joann Brooks, Margaret Willard, et al. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway [J]. Biochem Biophys Res Commun. 2007 Aug 3; 359(3): 716-22.

Xiaofei Li, Jun Qiu, Min Pan, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells [J]. Blood.2005 Sep 1; 106(5): 1824-30.

Meike Burger, Tanja Hartmann, Myriam Krome, et al. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1[J]. Int J Clin Exp Pathol. 2015 Sep 1; 8(9): 10743-51.

Jing-Xia Zhang, Hong-Zhi Dong, Bing-Wei Chen, et al. Characteristics of coronary arterial lesions in patients with coronary heart disease and hypertension[J]. Springerplus.2016 Jul 29; 5(1): 1208.

Shashank Jain, John Harris, Jerry Ware Platelets: linking hemostasis and cancer[J]. Arterioscler Thromb Vasc Biol.2010 Dec; 30(12): 2362-7..

Karen V Winther, Tine Jess, Ebbe Langholz, et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County[J]. Clin Gastroenterol Hepatol. 2004 Dec; 2(12): 1088-95.

Tuba İnal, Ceyda Anar, Gülru Polat, et al. The prognostic value of D-dimer in lung cancer [J]. Clin Respir J.2015 Jul; 9(3): 305-13.

Gloria de la Red, Dolores Tàssies, Gerard Espinosa, et al. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels [J]. Thromb Haemost. 2009 Feb; 101(2): 312-6.

Adams GN, Rosenfeldt L, Frederick M, et al. Colon cancer growth and dissemination relies upon thrombin,stromal PAR-1, and fibrinogen[J]. Cancer Research, 2015, 75(19): 4235–4243.

Grigoris T Gerotziafas, Chryssoula Papageorgiou, Mohamed Hatmi. et al. Clinical studies with anticoagulants to improve survival in cancer patients [J]. Pathophysiol Haemost Thromb. 2008; 36(3-4): 204-11.

Grigoris T Gerotziafas, Chryssoula Papageorgiou, Mohamed Hatmi. et al. Clinical studies with anticoagulants to improve survival in cancer patients[J]. Pathophysiol Haemost Thromb2008; 36(3-4): 204-11.

Xuefeng Yu, Fulan Hu, Qiang Yao, et al Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study [J]. BMC Cancer, 2016 Jul 14; 16:480.

Guo-Ying Wang, Nan Jiang, Hui-Min Yi, et al Pretransplant Elevated Plasma Fibrinogen Level is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation[J]. Ann Transplant. 2016 Feb 23; 21: 125-30.

Sabine Krenn-Pilko, Uwe Langsenlehner, Tatjana Stojakovic, et al An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients[J]. Breast, 2015 Oct; 24(5): 667-72.

Wei-Yu Xu, Hao-Hai Zhang, Xiao-Bo Yang, et alPrognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients [J]. World J Gastroentero, 2018 Apr 7; 24(13): 1451-1463.

Agnes Y Y Lee. Management of thrombosis in cancer: primary prevention and secondary prophylaxis[J]. Br J Haematol, 2005, 128(3): 291–302.

Antonis Vylliotis, Christos Yapijakis, Emeka Nkenke, et al Effect of thrombosis-related gene polymorphisms upon oral cancer: a regression analysis [J]. Anticancer Res, 2013 Sep; 33(9): 4033-9.